January 8, 2026

Acuitas Takes Majority stake in Montreal-based RNA Construct Manufacturer

Acuitas Therapeutics shelled out an undisclosed sum to acquire a majority stake in Montreal-based and privately held RNA Technologies & Therapeutics.